Enrotab
Enrotab
Authorised
- Enrofloxacin
Product identification
Medicine name:
Enrotab
Active substance:
- Enrofloxacin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin15.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- Box with 2 Alu-PVC PE PVDC blisters or Alu-PVC PVDC blisters with 10 tablets (20 tablets)
- Box with 15 Alu-PVC PE PVDC blisters or Alu-PVC PVDC blisters with 10 tablets (150 tablets)
- Box with 10 Alu-PVC PE PVDC blisters or Alu-PVC PVDC blisters with 10 tablets (100 tablets)
- Box with 6 Alu-PVC PE PVDC blisters or Alu-PVC PVDC blisters with 10 tablets (60 tablets)
- Box with 5 Alu-PVC PE PVDC blisters or Alu-PVC PVDC blisters with 10 tablets (50 tablets)
- Box with 3 Alu-PVC PE PVDC blisters or Alu-PVC PVDC blisters with 10 tablets (30 tablets)
- Box with 1 Alu-PVC PE PVDC blister or Alu-PVC PVDC blister with 10 tablets (10 tablets)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Artesan Pharma GmbH & Co. KG
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 104599
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0136/001
Concerned member states:
-
Hungary
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 13/06/2022
Dutch (PDF)
Published on: 24/01/2022
